What is Fabior and how does it work?
- Fabior Foam is a prescription medicine used on the skin (topical) to treat acne in people 12 years and older.
- Fabior (tazarotene) Foam, 0.1% is indicated for the topical treatment of acne vulgaris in patients 12 years of age or older.
- It is not known if Fabior Foam is safe and effective in children under 12 years of age.
What are the side effects of Fabior?
The most common side effects of Fabior Foam are:
- burning or stinging
- dry skin
- red skin
- peeling or flaking skin
Sometimes these symptoms can become severe and may be uncomfortable. Tell your doctor if these side effects become uncomfortable for you. Your doctor may tell you to stop using
Fabior Foam until your skin heals and your symptoms improve, or to use Fabior Foam less often to help you tolerate it better.
These are not all the possible side effects of
Fabior Foam. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800- FDA-1088.
You may also report side effects to Mayne Pharma at 1-844-825-8500.
What is the dosage for Fabior?
- Fabior Foam is for topical use only. Fabior Foam is not for oral, ophthalmic, or intravaginal use.
- Fabior Foam should be applied once daily in the evening after washing with a mild cleanser and fully drying the affected area. Dispense a small amount of foam into the palm of the hand. Using fingertips, apply only enough foam to lightly cover the entire affected areas of the face and/or upper trunk with a thin layer; gently massage the foam into the skin until the foam disappears. Avoid the eyes, lips, and mucous membranes. Wash hands after application.
- Patients may use moisturizer as needed.
- If undue irritation (redness, peeling, or discomfort) occurs, patients should reduce frequency of application or temporarily interrupt treatment. Treatment may be resumed once irritation subsides. Treatment should be discontinued if irritation persists.
What drugs interact with Fabior?
- No formal drug-drug interaction studies were conducted with Fabior Foam.
- Concomitant dermatologic medications and cosmetics that have a strong drying effect should be avoided. It is recommended to postpone treatment until the effects of these products subside before use of Fabior Foam is started.
- Concomitant use with oxidizing agents, such as benzoyl peroxide, may cause degradation of tazarotene and may reduce the clinical efficacy of tazarotene. If combination therapy is required, they should be applied at different times of the day (e.g., one in the morning and the other in the evening).
- The impact of tazarotene on the pharmacokinetics of progestin-only oral contraceptives (i.e., minipills) has not been evaluated.
- In a trial of 27 healthy female subjects between the ages of 20 to 55 years receiving a combination oral contraceptive tablet containing 1 mg norethindrone and 35 mcg ethinyl estradiol, concomitant use of tazarotene did not affect the pharmacokinetics of norethindrone and ethinyl estradiol over a complete cycle.
Is Fabior safe to take when pregnant or breastfeeding?
- There are no adequate and well-controlled studies with Fabior Foam in pregnant women. Fabior Foam is contraindicated in females who are or may become pregnant
- It is not known whether this drug is excreted in human milk. The safe use of Fabior Foam during lactation has not been established. A decision should be made whether to discontinue breastfeeding or to discontinue therapy with Fabior Foam taking into account the benefit of breastfeeding for the child and the benefit of therapy for the woman.